Author Archives: Antigone Barton

Can counseling, links to services cut death rates in half among people with HIV who inject drugs?

By on .

A study across three countries where HIV incidence is fueled by substance use found that a little support went a long way for people living with the virus and injecting drugs — helping them to stay on antiretroviral treatment and opioid substitution therapy, and keep their viral levels suppressed. The study, at health centers in […]

Yellow fever patient in Republic of Congo prompts outbreak declaration, response

By on .

Republic of Congo health officials are calling risks to public health at a national level high, and at a regional level moderate, after confirmation that a man was infected with yellow fever in a city densely populated with about a million people, as well as with mosquitos capable of spreading the virus, according to a […]

Delamanid delay comes home

By on .

Patient benefits from access to innovative drug that still awaits U.S. approval A note from the field in this week’s Morbidity and Mortality Weekly Report describes the case of a dangerously ill man in the United States. Weak, coughing, and losing weight, with pain in his chest, he was tested for tuberculosis, which it turned […]

Signs of Ebola control, cautious optimism reflect lessons, missed opportunities, continuing gaps

By on .

More than two million travelers checked at 37 points of entry — airports, river ports, and border crossings —  between the Democratic Republic of Congo and neighboring countries. More than six thousand people who had contact with the sick, including health workers, or with others who had contact with them, vaccinated. Three different investigational treatment […]

What we’re reading: Changes needed to stop Ebola, other threats of pan-epidemic potential

By on .

Health-care worker infections add to Ebola challenge in Congo – The challenges arising when a new Ebola outbreak surfaces in an area where the virus hasn’t been seen before include the exposure of frontline health workers without experience in necessary detection and protection measures. The resulting infections among medical staff who are needed most and […]

TB treatment trial aims to consign lengthier, more toxic regimens to history

By on .

With the enrollment of its first patients in Eastern Europe, the largest trial yet to test a four-drug, four-month treatment regimen against tuberculosis will set out to demonstrate whether fewer medicines, over a shorter length of time can cure nearly all TB patients. The trial, which will launch in Tbilisi, the capital of the country of […]

As deadline approaches for HIV control testing and treatment targets, sex workers still face “glaring gaps” between services and access

By on .

Authors of 2014 recommendations to tackle HIV among sex workers revisit literature and find impacts of pandemic, structural drivers continue to be “under addressed and under-resourced” When, in the months leading up to the 2014 International AIDS Conference in Melbourne, a team of researchers put together a series of articles examining the drivers and impacts  […]

Access to on-the-spot testing led to improved rates of treatment for infants with HIV

By on .

Tests to detect HIV in infants conducted at health facilities where they received care led to a significant increase in the percentage of infants with the virus given access to life-saving treatment, compared to tests analyzed in central laboratories, according to a report in Clinical Infectious Diseases. The report notes that the findings have critical […]

What we’re reading: Tracking infections and opioids, treating TB, Kofi Annan and global health — following evidence to do the right thing

By on .

Infectious disease monitoring: More care needed to control impacts of opioid crisis – Surveillance that spots rises in rates of diseases linked to injecting drug use, care that combines treatment for addiction and for infections, and a workforce trained and ready to respond to the opioid crisis across Kentucky and the nation are needed now, […]

WHO recommends superior, injection-free regimen for drug-resistant TB

By on .

New, more effective medicines replace painful daily shots, drugs causing psychosis, permanent hearing loss; TB and medical communities welcome change, say recommended drugs must be accessible, affordable Saying rates of cured cases of drug-resistant tuberculosis could be increased with access to an oral regimen of newer, more effective and less toxic medicines, the World Health Organization […]